Attorneys representing several plaintiffs with claims stemming from their use of the antibiotics Levaquin, Avelox and Cipro have asked the Philadelphia Court of Common Pleas to consolidate the cases into a mass tort program.
Last week, three lawyers representing 32 plaintiffs with claims against Bayer Corp. and Janssen Pharmaceuticals sent a petition to Philadelphia Administrative Judge Kevin M. Dougherty, seeking to have the pending cases designated as a mass tort. The petition, filed in the case Whitters v. Bayer, said the attorneys anticipate filing at least 30 more cases in the near future.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
